13F filer

Emerald Advisers

As of Jun 30, 2026 Filed Aug 5, 2026 CIK 1015083 SEC filings ↗
13F Value
$4.25B
Positions
237
Top Position
TVTX2.1%
Top 5
9.4%

Latest filing changes

vs Mar 31, 2026
1 CORT Corcept Therapeutics +264.0%+$47.2M
2 ACLS Axcelis Technologies +243.4%+$44.4M
3 IDCC Interdigital +114.8%+$33.8M
5 CYTK Cytokinetics +130.3%+$22.1M
Holdings237
# Trend (4Q)
1 TVTX 2.1% $90.9M +2.8% 1.60M 1.5% Common Stock
2 CDNL 1.9% $79.9M +46.6% 848.0K 0.7% Common Stock
3 MRCY 1.8% $78.1M +7.3% 638.7K 1.4% Common Stock
4 AIR 1.8% $74.6M +17.1% 521.9K 1.5% Common Stock
5 VSEC 1.7% $73.8M +2.7% 323.2K 1.8% Common Stock
6 KLIC 1.7% $73.8M -3.1% 551.5K 1.2% Common Stock
7 AGX 1.7% $71.3M -6.3% 89.3K 1.6% Common Stock
8 CECO 1.6% $66.9M +40.9% 736.8K 1.0% Common Stock
9 CORT 1.5% $65.1M +264.0% 748.3K 0.3% Common Stock
10 LIVN 1.5% $64.7M +17.4% 787.1K 1.3% Common Stock
11 SMTC 1.5% $63.6M -14.0% 393.0K 1.1% Common Stock
12 IDCC 1.5% $63.3M +114.8% 223.5K 1.0% Common Stock
13 ESE 1.5% $62.9M +10.5% 179.8K 1.4% Common Stock
14 ACLS 1.5% $62.6M +243.4% 330.5K 0.3% Common Stock
15 PDFS 1.5% $62.6M +2.7% 884.3K 0.9% Common Stock
16 PLXS 1.5% $62.5M +24.7% 207.7K 1.1% Common Stock
17 COHU 1.5% $62.4M +8.1% 843.6K 0.8% Common Stock
18 COGT 1.5% $62.0M +1.0% 1.60M 1.9% Common Stock
19 ALGT 1.3% $55.9M +40.6% 475.1K 0.9% Common Stock
20 LGN 1.3% $55.7M NEW 653.8K — Common Stock
Change compares with the prior filing. Prior % is the share of the portfolio in that filing. Trend shows the quantity held in each of the last four filings: green rose, red fell, grey unchanged.
Exited in Latest Filing39
# Holding Prior % Prior Value Change Prior Quantity Trend (4Q) Type
Compared with the immediately prior published filing (Mar 31, 2026). Prior values are shown for context and are not included in current totals.